logo
Plus   Neg
Share
Email

Merck Lifts FY21 Outlook

German drug giant Merck KGaA on Tuesday lifted forecast for full-year 2021, reflecting high demand anticipated throughout the year and good first-quarter results.

For the full year, the company now expects net sales between 18.5 billion euros and 19.5 billion euros. Earlier, Merck had said that it expects to deliver strong organic net sales growth, helped mainly by Healthcare and Life Science business sectors.

Full-year EBITDA is expected to reach between 5.4 billion and 5.8 billion euros, while the company had earlier anticipated organic EBITDA growth in a high single-digit to low teens percentage range, excluding the release of the provision in 2020.

In fiscal 2021, earnings per share is expected between 7.50 euros and 8.20 euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT